I am pleased to announce that Joseph Guglielmo, PharmD, has been named Interim Dean of the School of Pharmacy, effective July 1. His appointment has been approved by The UC Regents, and a search is under way for a permanent dean to replace Mary Anne Koda-Kimble, PharmD, who will retire from UCSF at the end of June.
In its decades as the pre-eminent school of pharmacy, the school has never been stronger. It continues to lead the nation in NIH support for pharmacy-related research and to serve as a bellwether for the field. The school not only is successfully recruiting the top faculty and most promising students and conducting world-class research, but also is advancing into new territories such as bioengineering, devices and diagnostics.
Joe has ably served the school and University for 33 years and has been closely involved with the continuing development of the school's top-ranked doctor of pharmacy curriculum, while leading his department in attracting record research funding. Joe is chairman of the Department of Clinical Pharmacy, a position he has held since 2006, and serves as the assistant director of Pharmaceutical Services for the UCSF Medical Center, enabling it to build upon the most advanced clinical research in pharmaceutical care to constantly improve medication use and safety. In addition, Joe holds the Thomas A. Oliver Endowed Chair in Clinical Pharmacy and served the campus as chair of the Committee on Academic Personnel for the Academic Senate from 2003-2005.
Joe earned a doctor of pharmacy degree from the University of Southern California and joined the UCSF School of Pharmacy in 1979 after a UCSF residency in pharmacy practice. He is a nationally recognized expert on the use of drugs to control infection, and his research has been widely published in professional journals. In addition to having received several teaching awards, his knowledge has been shared worldwide through his contributions as an editor of Applied Therapeutics and Handbook of Applied Therapeutics, and as author or editor of chapters in other textbooks, including Current Medical Diagnosis and Treatment.
This is a tremendously exciting time for the school. Mary Anne is leaving an impressive legacy, having strengthened and expanded laboratory-based research programs, cultivated efforts to move research discoveries closer to clinical application, and supported the development of new ways for pharmacists to share their unique and much-needed medication expertise. I am confident that with Joe’s leadership, the School of Pharmacy and UCSF will continue on this path of excellence.
Please join me in supporting Joe as he leads the finest pharmacy school in the nation.
Susan Desmond-Hellmann, MD, MPH
Arthur and Toni Rembe Rock Distinguished Professor